US Broker Ratings

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 52.91% Potential Upside

BridgeBio Pharma, Inc. (BBIO), a prominent player in the healthcare sector, specifically in biotechnology, offers a fascinating investment opportunity with significant potential upside. With a market..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 36.39% Upside Potential

Telix Pharmaceuticals Limited (TLX), a biopharmaceutical company based in North Melbourne, Australia, is capturing investor attention with its significant 36.39% potential upside. Operating primarily in the..

Glaukos Corporation (GKOS) Stock Analysis: Eyeing a 31.69% Potential Upside

Glaukos Corporation (NASDAQ: GKOS), a prominent player in the healthcare sector, is making waves with its innovative medical devices designed to treat a range of ophthalmic..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Digital Healthcare Leader with Robust Revenue Growth

iRhythm Technologies, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry. Known for its cutting-edge cardiac monitoring technology,..

Regencell Bioscience Holdings L (RGC): Investor Outlook on the Unique Growth Potential in Traditional Chinese Medicine

Regencell Bioscience Holdings Limited (RGC) presents an intriguing opportunity for investors looking to tap into the healthcare sector’s niche of Traditional Chinese Medicine (TCM). Headquartered in..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Pioneer with Robust Growth but Limited Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its cutting-edge medical devices designed to revolutionize organ transplant therapy. The company’s flagship..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Biotech Innovator with 90% Revenue Growth and Strategic Focus on MS Treatment

TG Therapeutics, Inc. (NASDAQ: TGTX) has captured investor attention with its impressive 90.40% revenue growth and a strategic focus on developing treatments for B-cell mediated diseases...

HealthEquity, Inc. (HQY) Investor Outlook: Strong Buy Ratings Signal Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) is capturing the attention of investors with its robust position in the healthcare sector, specifically in the health information services industry. Based..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unlocking a 69.73% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is drawing attention from investors with an enticing potential upside of 69.73%. Headquartered in..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Promising 57% Upside in Healthcare Innovation

Inspire Medical Systems, Inc. (NASDAQ: INSP), a leading name in the healthcare sector, is making waves with its innovative approach to treating obstructive sleep apnea (OSA)...

Bio-Techne Corp (TECH) Investor Outlook: Analyzing a 41.61% Potential Upside Amid Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH) is a noteworthy player in the biotechnology sector, offering a mix of life science reagents, instruments, and services. Headquartered in Minneapolis, Minnesota,..

The Ensign Group, Inc. (ENSG) Stock Analysis: An 8.39% Upside in the Healthcare Sector

The Ensign Group, Inc. (ENSG), a stalwart in the healthcare sector, with a focus on medical care facilities, is capturing the attention of investors with its..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a 26% Potential Upside in Healthcare Plans

Oscar Health, Inc. (NYSE: OSCR) presents an intriguing opportunity for investors looking to tap into the healthcare sector, particularly within the realm of healthcare plans. As..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Evaluating Growth Amidst a 4.04% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. The company,..

Chemed Corp (CHE) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Chemed Corp (CHE), a prominent player in the healthcare sector, offers a unique mix of hospice care and commercial services through its VITAS and Roto-Rooter segments...

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Closer Look at Valuation and Growth Prospects in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading player in the global pharmaceutical industry, presents a compelling case for investors with its robust revenue growth and..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a 31% Potential Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), operating within the dynamic healthcare sector, has garnered significant attention from investors due to its robust presence in the medical instruments and..

Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Growth with a 22.6% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, operates as a contract development and manufacturing company specializing in medical devices. With a..

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing a 239.96% Potential Upside

Vaxcyte, Inc. (NASDAQ: PCVX), a promising player in the biotechnology sector, has caught the eye of investors with a remarkable potential upside of 239.96%. This clinical-stage..

BeOne Medicines Ltd. (ONC): Investor Outlook on a Biotech Powerhouse with 29.81% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is catching the attention of investors with a compelling potential upside of 29.81% as per..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds